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The neural crest (NC) is a multipotent migratory embryonic population that is formed during late 
gastrulation and gives rise to a wide array of derivatives, including cells from the peripheral 
nervous system (PNS), the craniofacial bones and cartilages, peripheral glial cells, and melanocyte 
cells, among others. In this work we analyzed the role of the Hedgehog signaling pathway effector 
gli2 in Xenopus NC. We provide evidence that the gli2 gene is expressed in the prospective, 
premigratory and migratory NC. The use of a specific morpholino against gli2 and the 
pharmacological specific inhibitor GANT61 in different experimental approaches allowed us to 
determine that gli2 is required for the induction and specification of NC cells as a transcriptional 
activator. Moreover, gli2 also acts by reducing apoptosis in the NC without affecting its cell 
proliferation status. We also demonstrated that gli2 is required cell-autonomously for NC migration, 
and for the formation of NC derivatives such as the craniofacial cartilages, melanocytes and the 
cranial ganglia. Altogether, our results showed that gli2 is a key transcriptional activator to 
accomplish the proper specification and development of Xenopus NC cells.  
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The neural crest (NC) is a multipotent embryonic cell population with stem-cell-like 
properties that arises at the border between the neural plate (NP) and the prospective 
epidermis, and migrate along the entire embryo. This cell population, which separates the 
craniates/vertebrates from other metazoans, has played a key role in the evolutionary 
development of the jaw and other cranial structures (Saint-Jeannet, 2006). Derivatives from 
the NC include neurons and glia of the sensory, autonomic and enteric nervous system, 
medullary secretory cells, bone marrow cells from the femur and other long bones, smooth 
muscle cells, melanocytes, bone and cartilage cells, among other cell types (Couly et al., 
1998; Keyte et al., 2014; Vega-Lopez et al., 2017). Increasing research in recent years has 
focused on NC development based on the fact that the abnormal formation of this cell 
population can give rise to a diverse class of pathologies known as neurocristopathies 
(NCP), which affect a large proportion of newborns (Vega-Lopez et al., 2018; Watt and 
Trainor, 2014). Therefore, studying the mechanisms underlying NC formation is a necessary 
step for the isolation of multipotent NC stem cells that could act as potential sources for the 
treatment of several of these NCP and many NC-related cancers (Liu and Cheung, 2016). 
Interactions between distinct signaling pathways such as BMP, FGF, Notch and Wnt 
play a key role in the development of the NC. These signals, along with other molecules, 
participate in establishing a gene regulatory network that is crucial to determine NC identity 
(Martik and Bronner, 2017; Sauka-Spengler and Bronner-Fraser, 2008). Hedgehog (Hh) 
ligands include Sonic Hedgehog (Shh), Indian Hedgehog (Ihh) and Desert Hedgehog (Dhh) 
(Wu et al., 2017). We have previously found in Xenopus embryos that the Indian Hedgehog 
(Ihh) signaling pathway is active in the NC tissue, and that it is required for the development 
of this cell population (Aguero et al., 2012). We also revealed the regulatory relationships 
between this pathway and the eg5 gene in the NC (Fernandez et al., 2014). The Hh 
signaling pathway plays important roles in development, tissue homeostasis and 
tumorigenesis. Signaling is initiated when the ligand binds to the receptor Patched1 (Ptch1). 
When unbound, Ptch1 inhibits the activity of a second receptor called Smoothened (Smo), 
which is responsible for the activation of the pathway effectors, the Gli transcription factors 
(Gli1, Gli2 and Gli3). These transcription factors are post-translationally regulated and act in 
a context-dependent combinatorial fashion (Chen and Jiang, 2013; Ruiz i Altaba et al., 
2007). When the Hh signal is absent, Gli2 and Gli3 are proteolytically processed into 
repressor forms (GliRep), whereas when the pathway is active, they act as full length 

















Gli2, the main activator of the Hh signaling pathway, stimulates the transcription of 
several target genes (Kim et al., 2009). In Xenopus embryogenesis, Gli proteins play a 
crucial role during neurogenesis, inducing different neuronal types through a cooperative 
and combinatorial action (Nguyen et al., 2005). Gli2 has been shown to participate in 
several developmental processes, acting as a transcriptional activator. These processes 
include palate development (Mo et al., 1997), lung and pituitary gland formation (Ding et al., 
1998; Wang et al., 2010) and the generation of the central nervous system (Chen et al., 
2018; Lepanto et al., 2016; Matise et al., 1998). However, a repressor function of Gli2 has 
also proved to be important for the development of the zebrafish nervous system (Karlstrom 
et al., 2003). Therefore, since Gli2 regulates many cellular processes, it has been 
associated with disease when its regulation goes awry (reviewed in (McCleary-Wheeler, 
2014)). The growing number of therapeutic applications based on the function of Gli2 has 
generated a dramatic increase in the number of studies that analyze the function of this 
transcription factor. Nevertheless, despite great advances in the understanding of the 
mechanisms underlying the function of Gli2 during central nervous system development, 
little is known about the role of this transcription factor in the formation of the NC.  
In this work we address the participation of Gli2 in the formation of Xenopus laevis NC. 
We made a detailed analysis of the spatio-temporal expression pattern of this gene, thus 
complementing previous reports. Furthermore, using gain and loss-of function studies and 
RT-qPCR analysis, we show that gli2 is essential for the induction, specification and 
maintenance of the specification and migration of the NC. Mechanistically, our results also 
provide evidence that Gli2 is acting as a transcriptional activator in NC development. We 
also suggest that Gli2 might be required for the formation of NC derivatives such as 
craniofacial cartilages, melanocytes, Rohon Beard (RB) neurons and cranial ganglia 
primordia. By taking advantage of the Gli2-specific inhibitor GANT61, we corroborated the 
results obtained with the standard morpholino-based knock down approach. To summarize, 
by different approaches we have addressed the participation of this transcription factor in 

















2. RESULTS  
 2.1. Spatio-temporal expression patterns of gli2 and Ptc1 
Using simple and double in situ hybridizations (ISH), we performed a comprehensive 
analysis of the spatio-temporal expression pattern of the gli2 gene during the initial 
development of Xenopus laevis. During late gastrulation (stages 12 and 13), the expression 
of gli2 was observed in the dorsal region of the embryos at the anterior NP border (NPB) 
extending through the NP posteriorly with no expression at the dorsal midline. This gene 
was also expressed in the lateral posterior NPB (Figures 1A-B). At mid-neurula stages (st. 
15-16), the expression increased in the NPB (Figures 1C-D, yellow arrowheads), which 
corresponds to the prospective NC. During the course of neurulation we detected gli2 
transcripts in the anterior NP (black arrow). As development proceeded, at stages 16-17 
(Figure 1E, asterisk) gli2 expression was also observed in the mesoderm. When NC cells 
(NCC) started to migrate from the dorsal region of the embryo (stage 18), the expression of 
gli2 was located in the NC migratory region without apparent expression in the midline 
(Figures 1F-G). Additionally, at tailbud stages (Figures 1H-I), gli2 transcripts were detected 
in the head region of the embryo. Stage 24-embryos showed expression in the prospective 
branchial arches, in particular in the mandibular and hyoid NC streams, and also in the optic 
vesicle. Afterwards, at stage 32, the expression became more prominent in the boundaries 
between the branchial arches. At this point, gli2 expression in the optic vesicle became 
restricted to its borders. Additionally, gli2 was detected in the otic vesicle and in the 
segmentative presomitic mesoderm.  
To further delineate the expression of gli2 in the NC, we performed double ISH with NC 
and NP markers. At stage 15, a double ISH of gli2 with the NC marker foxd3 showed a clear 
overlapping expression of both genes in the inner region of the NC (Figure 1J). Transversal 
sections of these embryos revealed that gli2 expression occurred mainly in the internal 
ectodermal layer corresponding to the NP and prospective NC (Figure 1J’). Then we 
analyzed the NP marker sox2 and found an overlap in the expression of both genes in the 
lateral region of the NP as summarized in Figure 1K-K’. Additionally, gli2 expression (white 
arrowhead) expanded more anteriorly than that of sox2 (Figure 1K’’, anterior view, green 
arrowhead). These initial results suggest that gli2 is mainly expressed in the NC territory 
during late gastrulation and throughout neurulation.  
It is well known that ptch1 serves as a readout of the Hh signaling pathway as its 
expression is increased in response to the activation of the Hh pathway (Goodrich et al., 

















information about the embryonic locations where the Hh signaling is active. To that end, we 
analyzed the expression of the Ptch1 receptor by performing a wholemount 
immunohistochemistry (IHC) assay. We found that Ptch1 is expressed in the ectoderm at 
the dorsal side of the embryo (Figure 1L) at the gastrulation stage 11. By the end of 
gastrulation, at stages 12.5-13, Ptch1 is expressed in the anterior NPB (Figure 1M, yellow 
arrowheads) and is faintly expressed in the lateral NPB. At neurulation stages the 
expression of Ptch1 increases in the elevating neural folds, as depicted in Figure 1N-O. 
Figure 1O’ is a magnification of Ptch1 expression in the uprising neural folds that clearly 
shows Ptch1 expression in the NC cell outlines. This expression profile agrees with its role 
as a transmembrane receptor. To summarize, the scheme in Figure 1P shows the different 
domains of expression of gli2 (blue) and Ptch1 (green) along with the neural crest (foxd3, 
light yellow) and neural (sox2, pink) markers.  
Taken together, these results provide compelling evidence that gli2 is expressed in the 
prospective, premigratory and migratory NC, thus supporting a potential role in NC 
formation. In addition, the analysis of Ptch1 expression shows strongly suggesting that the 


















Figure 1. gli2 and Ptc1 expression patterns in Xenopus embryos. (A-G, J-K, M-O) Dorsal views of 
Xenopus laevis embryos, anterior side on the left. (L) Dorsal view, anterior side at the top. (J’, K’): Transversal 

















expressed in the dorsolateral region of the embryo at stages 12.5 and 13 (yellow arrowheads). (C-D) gli2 
transcripts are detected in the NPB at early neurula stage (yellow arrowheads) and in the anterior NP (black 
arrow). No expression can be observed in the dorsal midline (red arrowhead) (E-G). From stage 17 to 19, gli2 
becomes more prominent in the lateral and anterior NPB. (H-I) At tailbud stages, gli2 is expressed in the 
mandibular (mb) and hyoid (hy) NC streams, in the branchial arches (b.a.), in the otic (Ot) and optic (Op) 
vescicle and in the presomitic mesoderm (S). (J-K) Double ISH showing gli2 expression with two gene 
markers. (J-J’) gli2 is expressed in an overlapping territory with the NC marker foxd3. (K-K’) The domain of 
gli2 expression extends laterally from the NP, as evidenced by the double ISH with sox2 in whole embryos. 
(K’’) Anterior view showing that the expression of gli2 extends mores anteriorly than that of sox2. (L) At the 
late gastrula stage, Ptch1 is expressed in the dorsal side of the blastopore. (M-O) At neurula stages, Ptch1 
can be detected in the NPB and in the neural folds. (O’) Expression of Ptch1 in the cell membranes of 
ectodermal cells. (P) Diagram representing the expression domains of the Ptch1 protein (green) and the 
genes gli2 (blue), foxd3 (light yellow) and sox2 (pink).  
 
2.2 gli2 is required for the early induction of the NC 
The process of NC induction is complex and involves several steps of signal inputs, 
protein-protein interactions, and the combinatorial activity of different transcription factors. 
More specifically, during the early steps of NC formation, several molecules including 
signaling peptides and transcription factors act to establish the NPB, which thereof acquires 
a different molecular identity from the surrounding neural and non-neural ectoderm. 
Together, these factors are called NPB specifiers. These specifiers include the transcription 
factors pax3, snail1 and msx1 (Mayanil, 2013).  
Initially, in order to analyze the requirement of gli2 during the early steps of NC induction, 
we used the directed microinjection of a morpholino oligonucleotide against the translation 
initiation site of the gli2 mRNA, called gli2MO. As a first step we decided to evaluate the 
efficiency of gli2MO against gli2 in vivo and in vitro. A plasmid encoding a chimeric protein 
consisting of the first 92 aminoacid residues of Gli2 fused to a GFP protein (gli2GFP) was 
constructed. Subsequently we injected different amounts of gli2MO along with the mRNA of 
the gli2GFP, and the expression of GFP by fluorescence microscopy and Western blotting 
was evaluated. The injection of a control morpholino (CoMO) along with gli2GFP mRNA did 
not affect GFP expression in the embryo (Figure 2A, 100% of embryos, n=25). As shown in 
Figures 2B-C the injection of 2.5 ng/E and 5 ng/E of gli2MO caused a reduction in GFP 
expression in a dose dependent manner (100%, n=25, and 95%, n=25, respectively). At a 
gli2MO concentration of 10 and 27 ng/E the fluorescence was completely abolished 
(Figures 2D-E, 100%, n=25). To further analyze the effects of the morpholino on gli2GFP 

















embryos protein extract and found that the band intensity was noticeably reduced by the 
effect of the morpholino (Figure 2F). Thus, these two approaches allowed us to confirm the 
efficiency of gli2MO against gli2 expression.  
We subsequently carried out loss-of-functions studies to analyze the requirement of Gli2 
in the induction of the NC. gli2MO (27 ng/E) was microinjected into one dorsal blastomere of 
8-cell stage embryos together with the lineage tracer fluorescein dextran amine (FDA) to 
identify the injected side (Figure 2G). The analysis of the expression of the NPB markers at 
stages 13-14 showed that the injection of gli2MO produced a marked reduction in the 
expression of pax3 (Figure 2H, 71%, n=43), msx1 (Figure 2I, 61%, n=61) and snail1 (Figure 
2J, 70%, n=41). This result suggests that gli2 might be required for the early events of NC 
formation. We then evaluated the participation of gli2 in NC induction by the directed 
microinjection of gli2 mRNA (2.6 ng/E) in one dorsal blastomere of 8-cell stage embryos. 
We observed a strong increase in the expression of pax3 (59%, n=46), msx1 (66%, n=38) 
snail1 (72%, n=39) as shown in Figures 2K-M. The quantification of the different 
phenotypes is plotted in Figures 2N-O. These results reinforce the assumption that gli2 
would participate in the early events of NC formation. 
NC explant culture provides a way to specifically analyze the effect of certain chemicals 
exclusively on these cells, thus providing a detailed spatial and temporal control of the 
experiment. We have previously shown that the inhibition of Ihh signaling by the effect of 
Cyclopamine produces a decrease in the expression of the NC gene marker foxd3 (Aguero 
et al., 2012). Based on these results, we decided to evaluate the function of GANT61, a 
specific Gli2 inhibitor, in the induction of the NC by analyzing its effects on the expression of 
the foxd3 marker. GANT61 prevents Gli2 from binding to the DNA, thus precluding its action 
as a transcription factor (Agyeman et al., 2014; Lauth et al., 2007). Taking into account that 
the Gli1 protein is not directly modulated by Hh signaling and that it is not expressed in the 
NC (Nguyen et al., 2005; Suzuki et al., 2010), we can assume that the effects of GANT61 
on NC are only due to the inhibition of Gli2. Consequently, we performed NC explants 
containing the underlying mesoderm (NC+M) at stage 12.5 and incubated them with 50 µM 
GANT61 (or only the vehicle as control) until stage 16, when the explants were fixed and 
the expression of foxd3 was tested (Figure 2P). The inhibition of Gli2 by GANT61 produced 
a marked decrease in the expression of foxd3 (Figure 2Q, 80% of explants n=35) as 
compared with DMSO incubation, in which no reduction in foxd3 was detected (Figure 2R, 

















approaches to block Gli2 expression and function allowed us to suggest that this 
transcription factor is important in the early events that regulate NC formation.  
 
 
Figure 2. gli2 participates in the early induction of the NC. (A-E, H-M) Dorsal views of Xenopus laevis 
embryos at mid-neurula stage; anterior side is on the left. Arrowheads indicate the injected side, shown in 

















of gli2MO efficiency in vivo and in vitro. (A-E) in vivo assay. Merged fluorescence and clear field images of 
each embryo are shown as insets. (A) Normal GFP fluorescence was detected in the embryo coinjected with 
gli2GFP mRNA (2.6 ng/E) and CoMO (27 ng/E). (B-E) Embryos injected with gli2GFP and increasing 
concentrations of gli2MO (2.5 to 27 ng/E) evidenced a reduction in GFP fluorescence intensity. (F) in vitro 
analysis by Western blot shows a marked reduction in the expression of gli2GFP. α-tubulin expression was 
used as loading control. (G) Schematic representation of the gain- and loss-of-function experiments. (H-J) 
Analysis of gli2 requirement on NC induction. gli2MO-injected embryos show a reduced expression of the NC 
induction markers pax3, msx1 and snail1. (K-M) gli2 mRNA-injected embryos show an increase in the 
expression of the NPB markers pax3, msx1 and snail1. (N-O) Quantification of phenotypes shown in H-J and 
K-M, respectively. (P-R) The specific inhibition of Gli2 in NC explants incubated from stage 12.5 to 16 with 
GANT61 diminishes the expression of the NC marker foxd3.  
 
2.3. gli2 is required for the maintenance of NC specification 
After NC induction occurs, these cells are specified and acquire a distinct molecular 
signature that separates them from other ectodermal cells. In order to assess the 
requirement for gli2 in NC specification we analyzed the expression of the NC specifier 
genes foxd3, snail2 and sox9 after experimentally affecting gli2 function (Figure 3A). gli2MO 
injection produced a reduction in the expression of the NC markers foxd3 (64%, n=66), 
snail2 (92%, n=25) and sox9 (46%, n=13) on the injected side, as indicated in Figures 3B-D. 
To assess whether the effects produced by gli2 gain- and loss-of-function on NCC affected 
the other ectodermal cell populations, we tested the expression of the NP marker sox2 and 
the prospective epidermis marker xk81a (Figures 3E-F). The results showed that gli2 knock-
down produced an increase in the expression of sox2 (45%, n=69) as well as in the 
epidermal marker xk81a (74%, n=15). To assess this phenotype in the same embryo we 
performed a double ISH of the sox2 and xk81a markers after gli2MO injection. We observed 
a decrease in the NC territory at the expense of an increase in the expression of the 
markers sox2 and xk81a (Figure 3G, 75%, n=16). The quantification of the phenotypes is 
plotted in Figure 3H. These findings may imply that changes in NC territory are not a 
product of an increase in cell proliferation but could be due to changes in the ectodermal 
cell fate instead.  
Subsequently, we evaluated the effect of gli2 mRNA overexpression on the same gene 
markers. Figures 3I-N show that gli2 gain of function produced an increase in the 
expression of the NC specification markers foxd3 (56%, n=81), snail2 (58%, n=26) and sox9 
(53%, n=19). As might be expected, we found that the overexpression of gli2 produced a 
concomitant decrease in the expression of sox2 (Figure 3L; 53%, n=49) and xk81a (Figure 

















the same embryo by double ISH (Fig. 3N; 60%, n=20). Figure 3O shows the quantification 
of the above phenotypes. In order to target the overexpression of Gli2 directly to NCC in a 
temporally and spatially controlled manner we used the α3000gli2 construct. This plasmid 
uses the snail2 promoter to specifically direct the expression of downstream constructs to 
the NC (Vallin et al., 2001). The specific overexpression of gli2 (Figures 3P-Q) caused a 
clear increase in the expression of the NC markers foxd3 (54%, n=13) and snail2 (50%, 
n=14). To determine whether the effects seen on the NC are a result of the inhibition of the 
Gli2 function by gli2MO, we prepared a rescue construct, named CRgli2, which encodes the 
full-length Gli2 protein containing 6 mismatches in the nucleotide sequence recognized by 
the morpholino. The co-injection of CRgli2 mRNA along with gli2MO efficiently restored the 
disrupted expression of the markers foxd3 (60% of embryos with normal expression, n=48) 
and snail2 (53%, n=17) in the NC (Figures 3R-S). Moreover, to specifically rescue gli2 
function in the NC territory, we coinjected gli2MO along with the α3000CRgli2 plasmid, 
which carries the mutations in the MO binding site and is additionally transcribed under the 
snail2-promoter action only during NC specification. This experiment yielded a rescue in the 
expression of the snail2 marker (Figures 3T and 3V, 82%, n=22). Furthermore, as a control 
of morpholino toxicity, we injected CoMO and found that the expression of foxd3 was not 
affected (Figure 3U and 3V, 88%, n=17). Altogether, these results imply that Gli2 


















Figure 3. gli2 requirement in NC specification. (B-G, I-N, P-U) Dorsal views of Xenopus laevis embryos 

















expression of the genes is shown in purple. (A) Graphic representation of the experiments. (B-D) gli2MO-
injected embryos show reduced expression of the NC markers foxd3 (B), snail2 (C) and sox9 (D). (E-G) 
Increase in the expression of the NP marker sox2 and the epidermal marker xk81a after gli2MO injection. 
Figure G shows a double ISH of sox2 and xk81a, with brackets indicating the width of the NC domain. (I-N) 
The opposite effect is seen when gli2 is overexpressed in the NC territory. (H, O) Quantification of gli2MO and 
of gli2 mRNA effects on the expression of NC markers, respectively. (P-Q) Overexpression of gli2 with the 
construct α3000gli2 produced an increase in the expression of foxd3 and snail2. (R-S) Control of morpholino 
specificity. Coinjection of gli2MO morpholino along with a plasmid encoding a mutated gli2 at the morpholino 
binding site (CRgli2) rescued the expression of the NC markers foxd3 and snail2. (T) The injection of the 
α3000CRgli2 construct also rescued foxd3 expression. (U) The microinjection of CoMO did not alter foxd3 
expression. (V) Quantification of the experiments shown in Figures 3P-U. 
 
We then tested the pharmacological inhibition of Gli2 function with GANT61 during NC 
specification using three different approaches. The first one consisted of the injection of 
GANT61 at a concentration of 3 µM in one dorsal blastomere of 8-cell stage embryos 
(Stage 3). This low concentration was chosen to avoid possible toxic effects in the injected 
blastomere. Afterwards embryos were fixed at stage 16 and the expression of the NC 
markers foxd3 and snail2 was analyzed (Figure 4A). The loss of function of gli2 produced a 
marked reduction in the expression of the NC marker foxd3 (Figures 4B and 4F, 64% n=11) 
and snail2 (Figures 4C and 4F, 65%, n=20) on the injected side. In agreement with the 
results obtained with gli2MO, the injection of GANT61 produced an increase in sox2 
(Figures 4D and 4F, 47%, n=19) and xk81 expression (Figures 4E and 4F, 50%, n=8). As a 
control we injected the diluent of GANT61 (DMSO 0,03%) and analyzed the expression of 
the above mentioned markers (Figures 4G-K). We found that almost all embryos showed no 
change in gene expression between the control and the injected side (foxd3, 95%, n=20; 
snail2, 95%, n=22; sox2, 91%, n=23; xk81a, 95%, n=21) 
The second approach consisted in implanting GANT61-soaked beads into the NPB of 
stage 12.5 embryos, which were then fixed at stage 16 for the analysis of foxd3 expression 
(Figure 4L). The pharmacological inhibition of Gli2 produced a marked decrease in the 
expression of foxd3 on the injected side (Figures 4M and 4O, 57%, n=37) in contrast to 
control embryos implanted with DMSO-soaked beads, in which the majority of the embryos 
presented no change in expression (Figure 4N and 4O, 73% n=34). Finally, in the third 
approach we incubated NC explants with the underlying mesoderm in GANT61 from stage 
14 to 18, during which the specification of the NC takes place. The results showed a marked 
decrease in foxd3 expression when NC explants were treated with the inhibitor (Figure 4Q, 

















4R, 94% normal expression, n=36). These results showed that Gli2 is required for the 




















Fig 4. gli2 requirement for the maintenance of NC specification. (B-E, G-J, M-N) Dorsal views of 
Xenopus laevis embryos at midneurula stage; anterior side is on the left. Arrowheads indicate the injected or 
implanted side. (A-E) GANT61 injection at stage 3 produces a decrease in the expression of foxd3 and snail2, 
with a concomitant increase in the expression of sox2 and xk81a. (F) Quantification of phenotypes in the 
injected embryos of figures B-E. (G-J) Injection of the GANT61 diluent (DMSO 0,03%) produced no changes 
in the expression of the gene markers analyzed. (K) Quantification of phenotypes. (L-O) Implanted GANT61-
soaked beads from stage 12.5 to 16 produced a reduction in foxd3 expression, as opposed to the implantation 
of DMSO-soaked beads. (P-R) NC explants with mesoderm incubated in GANT61 from stage 14-18 lose 
foxd3 expression.  
 
2.4. The transcriptional activator form of gli2 acts on NC specification 
Our next step in the elucidation of the mechanism of action of Gli2 was to determine 
which functional form is responsible for eliciting the effects observed in NC induction and 
specification. It is known that in most cases Gli2 acts as a transcriptional activator 
(McCleary-Wheeler, 2014), but for some developmental contexts it has been shown that 
Gli2 might act as a transcriptional repressor (Bowers et al., 2012). With these facts in mind 
we prepared DNA constructs encoding functional forms of Gli2 lacking the N-terminal 
repressor domain (gli2act) and the C-terminal activator domain (gli2rep) in order to discern 
which functional variant is operating in the NC. These functional constructs of Gli2 have 
already been tested in other studies and have been found to activate, for the case of gli2act, 
and to repress (gli2rep) the expression of Hh target genes (Pan et al., 2006; Santos and 
Reiter, 2014; Sasaki et al., 1999). The summarized experimental procedure is indicated in 
Figure 5A. The directed microinjection of the activator form of gli2 (gli2act) produced an 
increase in the expression of the NC markers foxd3 (Figure 5B, 56%, n=32) and snail2 
(Figure 5C, 72%, n=28). Moreover, gli2act was also able to rescue the phenotype of the 
gli2MO-injected embryo (foxd3, Figure 5D, 45%, n=51; snail2, Figure 5E, 67%, n=15). 
Additionally, the NC-specific overexpression of the α3000gli2act construct rescued the 
morphant phenotype, producing an increased expression of foxd3 (Figure 5F, 75%, n=16) 
and snail2 (Figure 5G, 60%, n=15). Secondly, we tested the action of the repressor form of 
Gli2 (gli2rep). We found that gli2rep produced a consistent reduction in the expression of 
the markers foxd3 (Figure 5H, 78%, n=70) and snail2 (Figure 5I, 59%, n=54), indicating an 
inhibition of the specification of the NC. Therefore, as expected, the coinjection of gli2rep 
along with gli2MO produced no rescue in foxd3 (Figure 5J, 62% of embryos showing 
reduced foxd3 expression, n=16) and snail2 expression (Figure 5K, 53% reduced snail2 

















results strongly suggest that the transcriptional activator function of Gli2 is essential for the 
specification of the NC. 
In the canonical signaling, when the Hh pathway is inactive, Gli2 processing takes place 
as a result of multi-site phosphorylation at six conserved serine residues that occurs due to 
the sequential action of the kinases PKA, CK1 and GSK3. This phosphorylated version of 
Gli2 is ultimately processed by the proteasome and a large proportion of the protein pool is 
degraded, with the remaining part of the Gli2 protein acting as a transcriptional repressor 
(Pan and Wang, 2007). Conversely, when the Hh signal is present, the phosphorylation by 
PKA is prevented and therefore Gli2 is converted into a transcriptional activator 
(Niewiadomski et al., 2014; Riobo et al., 2006; Tuson et al., 2011). Accordingly, we created 
a mutant version of Gli2 in which the six PKA-target serine residues were changed into non-
phosphorylatable alanine residues, thus acting as a constitutive transcriptional activator 
when expressed in Xenopus embryos. This protein, unable to be phosphorylated and 
degraded, was called gli2PSM (gli2-PKA Site Mutation). The overexpression of this 
construct produced a marked increase in the expression of the markers foxd3 (Figure 5M 
and 5Q, 51% n=55) and snail2 (Figure 5N and 5Q, 60%, n=15), whereas it reduced the 
expression of sox2 (Figure 5O and 5Q, 59%, n=17) and xk81a (Figure 5P and 5Q, 61%, 
n=18). In addition, we overexpressed this construct in a NC-specific fashion through the 
injection of the plasmid α3000CRgli2PSM and found that it increased the expression of 
foxd3 (Figure 5R, 73%, n=22). Moreover, this construct was able to rescue foxd3 and snail2 
expression after gli2MO injection (Figures 5S-T, foxd3 81%, n=16; snail2 64%, n=14). The 
quantification of these experiments is shown in Figures 5Q and 5U.  
In summary, the results provide compelling evidence for a role of gli2 in the maintenance 
of the specification of the NC. In addition we also found that the transcriptional activator 



















Figure 5. The activator form of gli2 is required for NC specification. (A) Schematic procedure of the 
experiments. (B-K, M-P, R-T) Dorsal views of Xenopus laevis embryos at mid-neurula stage, anterior side to 

















foxd3 and snail2. (D-G) gli2act and α3000gli2act are able to rescue the expression of foxd3 and snail2 in the 
morphant embryo. (H-K) gli2rep represses the expression of foxd3 and snail2 and therefore is not able to 
rescue these expressions in the morphant embryo. (L) Quantification of effects shown in B-K. (M-P) The 
phosphorylation mutant gli2PSM increases the expression of NC markers and represses the activity of sox2 
and xk81a. (R-T) The α3000gli2PSM construct also increases the expression of foxd3 and is able to rescue 
the effects of gli2MO. (Q, U) Quantification of the experiments shown in M-P and R-T, respectively.  
  
 
2.5. gli2-mediated transcriptional activation modulates the expression of NC and 
NPB specifiers 
To further explore Gli2 role on NC development we studied the specific mechanism 
through which Gli2 exerts its function during NC specification. We analyzed the 
transcriptional activity of Gli2 using a Gli-dependent genetic reporter construct known as the 
8xGBS-Luciferase plasmid (8xGBS-LucII; GBS, specific Gli Binding Site) (Sasaki et al., 
1997). Embryos were injected in both dorsal blastomeres at stage 3 with the reporter 
plasmid (8xGBS-LucII) along with an internal control plasmid (pGL4.74-TK-hRluc, Promega, 
USA). These luciferase reporter constructs were coinjected with different in vitro-transcribed 
mRNAs and MOs in order to assess the effect of Gli2 on the transcriptional response of the 
reporter construct. For maximal tissue specificity and spatio-temporal control we dissected 
out NC explants for the luciferase assay. At stage 15-16 NC explants were dissected out 
and the firefly luciferase activity was assayed and normalized to the Renilla luciferase 
activity using a commercial kit (Dual-Luciferase Reporter Assay System, Promega, USA). 
The scheme of this experimental design is shown in Figure 6A. The injection of either gli2 or 
ihh mRNA produced a significant increase in Luciferase expression (Figure 6B). By using a 
mutated version of the 8xGBS domain (8xGBSmut-LucII plasmid) along with the coinjection 
of gli2 mRNA (2.6 ng/E), we found that the increased Luciferase activity produced by Gli2 
overexpression was abolished. This result indicates that the increase observed in 
Luciferase activity was only due to a stimulation of the 8xGBS promoter caused by Gli2. On 
the other hand, when we knocked down gli2 and ihh function with their respective MOs, a 
marked reduction in Gli-mediated Luciferase activity was observed. These results allow us 
to suggest that Gli2 acts as a transcriptional activator in the development of Xenopus NC.  
In order to determine whether gli2 was acting downstream of ihh in the gene regulatory 
network that participates in NC specification, we injected gli2 mRNA and ihhMO and 
observed that Gli2 was able to rescue the Luciferase expression back to the control levels. 

















Luciferase activity was markedly reduced. However, a small activation of the luciferase 
reporter still persisted, suggesting that other players could also act on the reporter construct 
in response to ihh stimulation. We speculated that Gli3 in particular could play this role in 
the activation of the 8xGBS promoter. We also decided to analyze the effect that the 
constitutive transcriptional activator form of Gli2, gli2PSM, elicits during NC specification. 
We observed that Luciferase activity increased up to eight times compared to Renilla 
luciferase activity. This indicates that the effects of gli2PSM injection on the expression of 
the NC markers shown in the previous section were produced by the transcriptional 
activator function of the protein encoded by this mRNA. Finally, we observed that Gli2 
inhibition by GANT61, produced by the incubation of NC explants from stage 13 to 16 with 
this inhibitor, caused a small, nonsignificant reduction in Luciferase activity with respect to 
the control embryo. Altogether, our results strongly point to a mechanism in which Gli2 
stimulates the transcription of target genes during the development of Xenopus NC.  
The expression of many genes must be tightly regulated for NC to develop properly. As 
noted previously, these genes are included in groups called NPB specifiers, NC specifiers 
and effector genes (Sauka-Spengler and Bronner-Fraser, 2008). To further investigate 
whether gli2 is involved in regulating the expression of such genes we performed 
quantitative RT-qPCR analysis of NC explants that were injected with either gli2MO or gli2 
mRNA. The specific genes analyzed were the NPB specifiers pax3, hairy2b and snail1, the 
NC specifiers snail2 and twist, and also the cell adhesion genes e-cad and n-cad. In this 
qPCR analysis gapdh was used as loading control. Embryos were injected in both dorsal 
blastomeres at stage 3, and at midneurula stages (st. 14-16) 200 NC explants were 
dissected out and the total RNA was extracted and analyzed by RT-qPCR. (Figure 6C). This 
gene expression analysis performed on the NC tissue showed the effect of gli2 specifically 
on NC development (Figure 6D). 
Regarding the expression of the NPB markers, we found that in the case of pax3, 
hairy2b, and snail2 the morpholino knock-down of gli2 produced a significant reduction in 
their expression, whereas the gain of function by overexpression of this gene increased the 
expression of these markers, with snail1 showing the higher increase in expression of the 
NPB genes analyzed. This analysis also showed that gli2 is required for their expression. 
The expression of the NC specifiers snail2 and twist, also showed a functional interaction 
with gli2 similar to the one found for the NPB genes, and twist1 was the most sensible gene 
to gli2 gain of function, showing a 14-fold increase in its expression, compared to the 

















and n-cad were downregulated when the gli2 function was knocked down. Only n-cad 
increased its expression after gli2 injection, suggesting a positive regulation of gli2 of its 
expression.  
 
Figure. 6. gli2 acts through a transcriptional activation mechanism and affects the expression of 
several NC markers. (A-B) Gli-Luciferase reporter assay. (A) Schematic representation of the Luciferase 
assay experiment. (B) Transcriptional activity of Gli2 in NC explants. Intensities are shown as relative units of 
Luciferase normalized to the internal control Renilla Luciferase. An increase in Gli2 and Ihh function increases 
the expression of the Gli-dependent reporter construct. (C-D) RT-qPCR analysis of Gli2 function on the 
expression of NPB and NC markers. Each color coded bar represents the relative expression level of the 
markers for each condition (gain and loss-of-function of gli2). All the expression levels denote Ct values that 
were normalized first to the expression level of gadph, and then they were normalized to the expression of 
each gene in the uninjected wildtype condition, and are presented as fold change. (C) Schematic 
representation of the grafting experiment. At stage 15-16 total RNA was isolated and then RT-qPCR was 
performed. (D) Expression levels of the markers pax3, hairy2b, snail1, snail2, twist-b, e-cad and n-cad. Data 
are presented as mean ± s.d. of triplicates of two independent qPCR experiments. Reference: **, P<0.05; ***, 
P<0.001 (P-values correspond to Student’s t-Test). 
 
2.6. gli2 is involved in the control of apoptosis of NCC but not in their proliferation. 
The above results suggest that gli2 might act on NC development by changing cell fate. 

















process or in the cell proliferation of NC during the specification period. In order to 
determine whether gli2 participates in cell proliferation we performed an IHC assay in which 
we analyzed changes in cell proliferation when we knocked down or overexpressed the gli2 
gene. The detection of proliferating cells was made by IHC against phospho-histone H3, 
which is present in cells undergoing mitosis. Our results showed that there were no 
significant changes in the number of proliferating cells between the injected and the control 
sides of embryos (n=8) for gli2MO or gli2 mRNA-injected embryos (Figures 7A-C). These 
results show that gli2 is not involved in the proliferation of the NCC during their induction 
and specification. 
We also tested whether the effects of gli2 function on NC were due to changes in the 
apoptotic process. We injected either gli2 mRNA or gli2MO in the dorsal blastomeres of 8-
cell stage embryos, grafted NC explants at mid neurula stage (n=20) and measured the 
caspase 3/7 activity with a homogeneous assay (Figure 7D, see Materials and Methods). 
The overexpression of gli2 produced a 2.5-fold reduction in caspase activity. This suggests 
that gli2 specifically plays a role in the apoptotic state of the NC. On the other hand, the 
injection of gli2MO had no effect on the apoptosis level of NCC. To further validate the 
specificity of gli2MO we coinjected it with CRgli2 and found that the apoptotic level of the 
NC was also reduced, similarly to gli2 overexpression. We also tested the ability of the gli2 
activator construct (gli2act) to control apoptotic levels, and found out that it reduced 
caspase activity levels even when we coinjected it with gli2MO (Figure 7E). These results 
suggest that the mechanism of action of Gli2 in NC specification might not be due to the 
regulation of the proliferative state of NCC, but that it may prevent cells from undergoing 



















Figure 7. gli2 is involved in the apoptosis of NCC but not in their proliferation. (A-B) Dorsal views of 
Xenopus laevis embryos, anterior side to the top. White arrowheads indicate the injected side. Gain- and loss-
of-function of gli2 did not alter the number of proliferating cells between the injected and the control side.  (A’, 
A’’, B’, B’’) Insets showing the quantified area of each embryo. (C) Quantification of proliferating cells in the 
embryos treated with gli2 mRNA or gli2MO. (D) Schematic diagram showing the approach used to evaluate 
the apoptosis status of NCC. (E) Graph showing that the overexpression of gli2 prevents NCC from 
undergoing normal apoptosis. The inhibition of gli2 expression did not produce any significant changes in the 
apoptosis level of NCC. The activator form of Gli2 also decreased apoptosis in NC explants. Values are mean 
± s.d. from two independent experiments. P≤ 0.05 (Student's t-test).  
 
2.7. gli2 is required for the proper migration of NC in a cell-autonomous process 
Migration of the NC is an essential process that allows these cells to colonize several 
regions of the embryo. Once the NC is already specified, effector proteins induce epithelial-
to-mesenchymal transition (EMT), delamination, and finally migration of the NCC. We 

















using gli2MO and the spatio-temporal control of GANT61 inhibitory action through soaked-
beads grafting. The first approach consisted in the targeted injection of gli2MO along with 
different gli2 constructs in a dorsal blastomere of stage 3 embryos, and the assessment of 
NC migration at stages 20-22 (Figure 8A). The loss of function of gli2 caused a reduction in 
the expression of foxd3 between the control side and the injected side (Figure 8B, 63%, 
n=16). This result was confirmed by the analysis of sox10 (Figure 8C, 70% n=33). We then 
determined the rescue of gli2 function by coinjecting CRgli2 and gli2act along with gli2MO. 
The results show that these mRNAs were able to restore the front of migration of NC as 
evidenced by foxd3 expression (Figures 8D, gli2CR, 69%, n=26; Figure 8E, gli2act, 50%, 
n=14).  
Subsequently, we knocked down gli2 function through the injection of the 
pharmacological inhibitor GANT61 at a concentration of 3 M. We found that GANT61 
produced a marked reduction in the front of migration of the NC as evidenced by the 
diminished expression of foxd3 (Figure 8G, 56% n=16). We next evaluated the function of 
Gli2 in NC migration in a more spatio-temporal specific manner. We implanted GANT61-
soaked beads into the NC of embryos at two time frames (Figure 8I and 8L). The first time 
frame comprised the stages of specification maintenance and onset of migration (stages 14-
22). Here we observed a marked reduction in the front of migration in the treated side, as 
shown by the expression of sox10 (Figure 8K, 56% n=43). Treatment with DMSO did not 
produce any significant changes (Figure 8J, 93%, n=28). This indicates that if gli2 is not 
properly functioning at the NC maintenance of specification period, NC migration is affected. 
The second experiment analyzed gli2 knockdown from stages 17 to 22. In this case 
GANT61 inhibition was performed at the beginning of NC cell migration and the results 
showed an impaired cell migration in the implanted side of the embryos (Figure 8N, 62%, 
n=45). As expected, DMSO treatment produced no changes in the front of migration (Figure 
8M, 89%, n=37). Altogether, being that in this particular assay Gli2 was interfered during the 
onset of migration, we can conclude that that gli2 is involved in the process of NC migration. 
The process of NC migration is complex, with different signals acting coordinately to 
trigger the EMT in NCC along with a change in the cadherin molecular signature. We 
previously found that the Ihh signaling pathway is essential for NC migration (Aguero et al., 
2012). Therefore, we decided to further explore the requirement of gli2 in this process. To 
that end, we knocked-down gli2 function by the microinjection of gli2MO, grafted NC 
explants at stages 17-18 into WT siblings and then analyzed NC migration under 

















uninjected NC control explants into wild type embryos. This produced a normal NC 
migration pattern in the host embryo as evidenced by the analysis of FDA fluorescence 
(Figure 8Q, 67%, n=18). When NC explants from embryos injected with gli2MO were 
grafted into wild type embryos, migration was severely affected (Figure 8R, 64%, n=11). 
Conversely, when uninjected NC explants were grafted into gli2MO-injected host embryos, 
migration was normal, undistinguishable from the untreated NC explants grafted into WT 
embryos (Figure 8S, 60%, n=10). These results show that gli2 acted in a cell autonomous 
manner in NCC migration, as this process only depends on proper gli2 function in the NC 


















Figure 8. gli2 acts in a cell-autonomous manner in NC migration. (B-E, G, J-K, M-N, Q-S) Lateral 
views of embryos with the anterior side on the left showing the expression of the NC migration markers sox10 
and foxd3. Figures Q-S show merged images of fluorescence and bright field captures. (A, F, I, L, P) 
Schematic representation of the different assays.  (B) Stage 20 embryos showing a reduction in the migration 
front in the injected side evidenced by the expression of foxd3. (C) In stage 22 embryos the difference in 
expression between the control and the injected side is notably higher, as evidenced by the marker sox10. (D-

















G) Injection of GANT61 produced a loss of gli2 function and a noticeable decrease in NC cell migration, as 
shown by the expression of foxd3. (H) Quantification of phenotypes shown in B-G. (I-N) Implantation of 
GANT61-soaked beads into NC at two different time frames (stages 14-22 and 17-22) produced a reduction in 
the front of migration of the NC as shown by sox10 expression. (O) Quantification of experiments shown in 
Figures I-N. (P-S) gli2 acts cell-autonomously in NC migration. Grafting of uninjected NC explant into an 
uninjected wild type embryo produced no alteration in the front of migration of the NC. The injection of gli2MO 
in the transplanted explant altered the normal pattern of NC migration. Grafting of a wild type NC explant into a 
gli2MO injected host produced no changes in normal NC migration.  
 
2.8. gli2 is required for the development of NC derivatives 
In order to further explore the role of gli2 on the development of the NC, we investigated 
the effect of gli2 knockout on NC derivatives. Embryos were injected with gli2MO, GANT61 
or with a combination of rescuing constructs at stage 3 and then, at stage 45, the analysis of 
cartilage morphology was performed by Alcian Blue staining (Figures 9A-B). The injection of 
GANT61 produced a slight reduction in the size of the cartilages (52%, n=27, Figure 9C). 
Interestingly, gli2MO-injected embryos showed a severe reduction in the size of the 
craniofacial cartilages in the injected side (Figure 8D, 71%, n=21). The gross morphology of 
craniofacial cartilages revealed that NC-derived cartilages (Meckel's, ceratohyal, and mostly 
the ceratobranchial cartilages) were severely reduced. The coinjection of CRgli2 was able to 
rescue the morphant phenotype, thereby proving the specificity of the gli2 function on NC 
derivatives formation (Figure 8E, 67%, n=21). As a control we injected CoMO and found no 
effect on craniofacial cartilage size or morphology (Figure 9F, 100% n=30), indicating that 
the observed effect was only due to gli2 loss of function. The quantification of the embryos 
is shown in Figure 9G. 
With the purpose of analyzing the role of gli2 in the development of craniofacial 
cartilages in a more temporally and spatially controlled manner, we grafted two GANT61-
soaked beads into the NC region of embryos either at stage 12.5 or 17 and analyzed their 
cartilage morphology at stage 45 (Figures 9H-M). In both treatments, the structure and size 
of the craniofacial cartilages were severely disrupted in the grafted side (Figure 9J and 9N, 
st.12.5-45 with GANT61, 59%, n=29; Figure 9M and 9N, stage 17-45 with GANT61, 63%, 
n=24), in contrast to the embryos implanted with DMSO-soaked beads (Figure 9I and 9N, 
st.12.5-45, 89% normal, n=28; Figure 9L and 9N, st.17-45, 93% normal, n=28). However, 
taking into account the fact that we affected Gli2 function during the beginning of NC 

















due to a deficit in NC migration or in the differentiation process. Therefore, future 
experiments are needed to address this issue. 
NCC are also responsible for the formation of different kinds of pigmented cells in the 
vertebrate body (Lapedriza et al., 2014). To further investigate the effects of gli2 in the 
formation of NC derivatives we analyzed the role of gli2 in melanocyte development. We 
found a remarkable decrease in melanocyte number at stage 36 in the injected side, 
suggesting a strong participation of gli2 in the development of this cell type (Figure 9O-Q, 
68%, n=22). We also decided to evaluate the effect of gli2MO in the formation of Rohon-
Beard (RB) sensory neurons and glia precursors, which in Xenopus laevis are marked by 
the expression of the tbx2 gene (Takabatake et al., 2000b). The results indicate that gli2 
loss of function produced a reduction in these cell populations (Figure 9R-T’, 69%, n=13). 
tbx2 expression also allowed us to conclude that, in the cranial region of the embryo, 
gli2MO produced a severe reduction in the trigeminal, the profoundal and the lens placodes. 
This suggests that gli2 might participate in cranial ganglia primordia formation. Taken 
together, these results suggest that gli2 is involved in the development of NC derivatives, 



















Figure 9. gli2 is required for the proper formation of NC derivatives. (A, H, K) Schematic 

















craniofacial cartilages. (C-F, I-M) Craniofacial cartilages preparation of stage-45 tadpoles. Alcian blue staining, 
ventral views of embryos, anterior side is at the top. Injected side is indicated by arrowhead. (C) GANT61 
injection at stage 3 produced a reduction in craniofacial cartilages, with a more prominent phenotype in the 
ceratobranchial cartilage. (D) The gli2MO-injected side of embryos (arrowhead) presents a marked reduction 
in Meckel’s, ceratohyal and ceratobranchial cartilages. (E) Rescue of cartilage morphology after coinjection of 
CRgli2 along with gli2MO. (F) CoMO-injected embryos showed no effect on the treated side. (G) 
Quantification of phenotypes shown in C-F. (H-N) Grafting of GANT61-soaked beads at two different time 
frames (st. 12.5 to 45 and 17 to 45) produced a consistent reduction in craniofacial cartilages. (O-Q) Lateral 
view of a gli2MO injected embryo. On the injected side there is a reduction in the number of melanocytes in 
the zone of the future gut. Quantification is shown in Figure 9Q. (R-T) tbx2 expression shows a reduction in 
RB neurons and cranial ganglia primordia on the gli2MO injected side. Pr, profoundal placode; L, lens 
placode; Ll, lateral line placode; Tp, trigeminal placode; RB, Rohon-Beard sensory neurons.  
 
2.9. Hierarchical Relationships of gli2 in early NC development 
To assess the function of Gli2 in the gene regulatory network that is essential for the 
formation of the NC, we analyzed its hierarchical relationships with other components of the 
Hh signaling pathway as well as with other genes involved in NC development. We have 
previously shown that the Ihh ligand is essential for the development of the NC during early 
Xenopus development (Aguero et al., 2012). Consequently, we set out to analyze the 
particular hierarchical relationship between gli2 and the ihh gene. Stage 3 embryos were 
injected with ihh or coinjected with gli2MO and ihh mRNA, and the expression of foxd3 was 
analyzed. ihh overexpression alone produced an increase in the expression of foxd3 (Figure 
10B, 72%, n=50), whereas the knockdown of its function decreased the expression of foxd3 
(Figure 10C, 73%, n=51) (Aguero et al., 2012).The combination of ihh and gli2MO blocked 
the effect of the ihh overexpression and produced a strong reduction in NC population 
(Figure 10D, 75%, n=20), whereas the opposite combination, i.e, ihhMO and gli2 mRNA, 
rescued the phenotype produced by the lack of ihh (Figure 10E, 75%, n=28). This result 
suggests that gli2 acts downstream of ihh in the signaling cascade in Xenopus laevis early 
NC development. 
Additionally, we evaluated the epistatic relationship between gli2 and gli3. The 
overexpression of gli3 mRNA caused an increase in NC territory (Figure 10F, 81%, n=70). 
Moreover, knocking down gli3 function diminished foxd3 expression (Figure 10G, 75%, 
n=60). When we coinjected gli2 mRNA along with gli3MO, we observed a remarkable 
rescue in the expression of the NC marker foxd3 (Figure 10H, 69%, n=16). On the other 
hand, when we coinjected gli2MO along with gli3 mRNA, we also observed a rescue of gli2 

















55%, n=40). This might be indicative of a possible redundancy in the function of both genes 
during the gene regulatory network that forms the NC.  
We also studied the epistatic relationship between gli2 and the ednra gene. Ednra 
signaling is required for early NC development, as the modulation of its functions affects 
foxd3 expression in the NC (Figure 10J-K, (Bonano et al., 2008)). In particular, 
overexpression of ednra causes an increase in foxd3 expression (Figure 10J, 65%, n=40), 
while its knockdown reduces the expression of this NC marker (Figure 10K, 73%, n=70). In 
the epistatic analysis, when ednra mRNA was coinjected with gli2MO, no rescue of foxd3 
expression was observed (Figure 10L, 63% n=41). Conversely, gli2 overexpression was 
able to rescue the reduced foxd3 expression in embryos treated with ednraMO (Figure 10M, 
69% n=59). This combinatorial analysis allowed us to suggest that gli2 acts downstream of 
the ednra gene during NC induction and specification.  
Finally we sought to establish the relationship between gli2 and the kinesin Eg5, which 
has been previously shown to participate in the processes that regulate the development of 
the NC (Figures 10N-O, (Fernandez et al., 2014). We observed that the overexpression of 
eg5 mRNA produced a marked increase in the expression of foxd3 (Figure 10N, 77%, 
n=60). On the other hand, when we injected eg5MO, foxd3 expression was reduced ion the 
injected side (Figure 10O, 85%, n=40). We then proceeded to the epistatic assays. The 
coinjection of eg5 mRNA could not rescue foxd3 expression produced after gli2 knockdown 
(Figure 10P and 10R, 66% of reduced expression, n=29). Conversely, gli2 mRNA 
coinjected along with eg5MO produced a striking rescue in the expression of foxd3 (Figure 
10Q and 10R, 70% n=10). Therefore, gli2 might act downstream of eg5 during NC 
specification.  
In summary, in this section we showed that gli2 is downstream of several genes that are 
important during NC development, indicating that these genes may possibly interact in order 
to establish the molecular framework for the development of the NC. The proposed model 


































Figure 10. gli2 epistatic relationships with ihh, gli3, ednra and eg5. (A) Schematic representation of 
the experiments performed. (B-Q) Dorsal views of Xenopus laevis embryos at mid-neurula stage; anterior side 
is on the left. Arrowheads indicate the injected side, shown in turquoise. The images show combinatorial 
experiments performed to evaluate the epistatic relationship between gli2 and different genes involved in the 
gene regulatory network that induces the NC. They also show the effect of individual genes on the NC. (B-E) 
gli2 is downstream of ihh during NC induction. (F-I) gli2 and gli3 rescue each other’s deficiency during NC 
induction. (J-Q) Both genes ednra and eg5 act upstream of the gli2 transcription factor during NC induction 
and specification. (R) Quantification of the phenotypes shown in B-Q. (S) Hierarchy diagram plotting the 


















NC formation involves a complex network of molecular actors, i.e., receptor/ligand-
signaling systems that translate environmental cues to specific molecules into the cell to 
control cellular behavior. Gli2 is a key transcription factor during vertebrate development 
and is also indispensable for the maintenance of homeostasis in the adult organism. 
Additionally, a misregulation of its function has been shown to cause a wide array of 
different congenital diseases and many types of cancers (McCleary-Wheeler, 2014). 
Therefore, it is crucial to understand the regulation of Gli2 and its function in different 
developmental processes in order to unveil its mechanisms of action and for the 
development of novel therapeutical molecules and treatments. In this study, we investigated 
gli2 requirement in NC development through different molecular, pharmacological and 
embryological approaches. We found that Gli2 is a key regulator of early embryogenesis 
required for NC induction, specification, migration and differentiation acting as a 
transcriptional activator.  
The onset of NC specification occurs during late gastrulation (Stuhlmiller and García-
Castro, 2012). We found that gli2 was expressed in the NPB and NC from late gastrulation 
onwards, undoubtedly indicating a role in the early events that define the NC population and 
the later processes required for its migration. Thus, this study provides an extensive 
analysis of the gli2 expression pattern that complements previous analyses (Aguero et al., 
2012; Michiue et al., 2017; Perron et al., 2003; Rankin et al., 2016). Moreover, we 
independently analyzed Ptch1 expression by wholemount IHC. The product of ptch1 gene, 
a well-known target of Hh signaling, was found in the NC territories during neurulation in 
expression domains fully compatible with a role in the early NC developmental processes. 
These results are in agreement with previous findings that partially showed ptch1 
expression (Rorick et al., 2007; Takabatake et al., 2000a), and with its use as a readout of 
Hh activity in the neural fold (Aguero et al., 2012). Recently, a comprehensive transcriptome 
analysis of ectodermal dissected regions from Xenopus embryos was made available 
through a searchable tool called EctoMap (Plouhinec et al., 2017). The gli2 and Ptch1 
expression patterns described here were compared with this database and we found that 
the gli2 L-homeologous has a higher relative expression and is the one that most closely 
resembles the expression pattern found in this study using ISH in the NC at neurula stages. 
Moreover, ptch1 expression in EctoMap recapitulates the expression found in this work. 

















On the other hand, our expression pattern found gli2 transcripts in the anterior NP 
throughout neurulation, which coincides with the role of gli2 as an essential factor in the 
development of the telencephalon, and as a causative factor for holoprosencephaly when it 
is mutated (Roessler et al., 2003; Takanaga et al., 2009). During vertebrate development, 
NCC are essential for the formation of ocular tissues such as the corneal endothelium, the 
corneal stroma and the sclera (Evans and Gage, 2005; Williams and Bohnsack, 2015). The 
expression of gli2 in the optic territory during tailbud stages concurs with the role of NC in 
ocular development, and also agrees with the role that Hh plays during the development of 
Xenopus retinal pigment epithelium (Perron et al., 2003). Finally, gli2 was also detected in 
the developing somites, which is consistent with the fact that gli2 is a direct target of the 
myogenic regulatory factor myoD in Xenopus development (McQueen and Pownall, 2017).  
NC induction is a complex multi-step process involving many diffusible molecules, 
signaling pathways and transcription factors that interact to shape the specification and 
identity of NPB cells in order for them to become NC-fate restricted cells. Here, we provide 
evidence that gli2 is required for the expression of a subset of these genes in the early 
specification steps. This fact puts gli2 in a pivotal position during the initial steps that give 
ectodermal cells the NPB identity. We also corroborated the timing of gli2 requirement in NC 
induction through two approaches using the specific inhibitor GANT61. The NPB genes 
particularly affected by gli2 gain-and loss-of-function include pax3, msx1, snail1, zic3 and 
zic5 (Aybar et al., 2003; Groves and LaBonne, 2014; Monsoro-Burq et al., 2005; Nakata et 
al., 2000; Nakata et al., 1997; Tribulo et al., 2003). Moreover, by a RT-qPCR assay of NC 
explants, we found that gli2 is required for the expression of NPB specifiers genes pax3, 
hairy2b and snail1 (Aybar et al., 2003; Vega-Lopez et al., 2015). These findings support a 
role for gli2 in the early steps of NC development.  
Once the NPB territory is competent to become NC, additional signals are integrated to 
maintain NC specification. These factors are called NC specifiers and are crucial in 
establishing NC identity (Duband et al., 2015; Pegoraro and Monsoro-Burq, 2013). 
Moreover, they are important for the EMT transition and the subsequent migration of NCC. 
We scrutinized the role of gli2 in this process through microinjection and NC-explant assays 
and found that it modulates the expression of key NC specifiers. We found by qPCR 
analysis that gli2 regulated the expression of the NC specifiers snail2 and twist1, confirming 
the role of gli2 in the specification process of the NC. It could be argued that gli2 might 
indirectly control the expression of these genes by initially controlling the expression of the 

















However, considering that NC induction does not fully confer a certain fate to NPB cells but 
enables them to respond to other signaling cues, acting as progenitor cells (Roellig et al., 
2017), it is possible that gli2 input is indeed necessary for both processes in a direct way. 
However, it remains to be determined whether gli2 acts in this fashion by directly binding to 
promoters of some NC specifiers to control the specification of the NC.  
NC transcription factors operate by activating or repressing the expression of their target 
genes. Gli2 could act as a transcriptional activator or repressor depending on the particular 
status of the Hh signaling (Ruiz i Altaba et al., 2007). We designed and constructed different 
functional variants to assess which form of gli2 participates in NC development. We found 
that the activator form of Gli2 is responsible for the induction and specification of the NC, as 
evidenced by the transcriptional responses of foxd3 and snail2 marker genes. Additionally, 
we found that the repressor form of gli2 reduced the expression of such markers. Moreover, 
the gli2PSM construct, which lacks the phosphorylation sites for PKA and behaves only as a 
transcriptional activator, also increased the NC markers expression during initial 
specification. Additionally, by performing a Gli-dependent luciferase activity assay on NC 
explants, which uses 8 tandem Gli-binding sites driving the luciferase construct, we 
confirmed that Gli2 acts as a transcriptional activator during NC development. Different 
combinatorial experiments on NCC showed that gli2 responds to ihh for the proper 
activation of its target genes. Interestingly, the injection of the gli2PSM construct produced a 
dramatic increase in the expression of the reporter construct, thereby confirming the 
activator role of Gli2 during NC morphogenesis. Altogether, our results point to the fact that 
this transcription factor acts as an activator to specify the NC. These results extend the 
current insights of Gli2 functions in embryogenesis, specifically during NC development.  
Gli2 is expressed in the NP and, as shown here, also in the NPB and the neural fold, and 
is essential for the D-V patterning of the NP through the control of several specific genes 
(Pal and Mukhopadhyay, 2015). The fact that the same molecule can control the expression 
of different genes in contiguous territories suggests that this transcription factor responds 
differently in each cell population. With respect to this question, one possibility could be 
argued in favor of the Hh ligand that stimulates the pathway. Based on our previous 
expression pattern and the functional analysis the Gli2 protein, we postulate that this protein 
receives the signal from the Ihh ligand in the NC, and not from Shh secreted from the 
notochord and the floor plate (Aguero et al., 2012). Secondly, the differential activity of Gli2 
between the NC and the NP could be explained by proposing that NC-specific expression of 

















context for the action of Gli2. During NC development, one possible candidate for the 
differential action of Gli2 could be Pax3, one of the NC earlier specifiers (Monsoro-Burq et 
al., 2005), which has been shown to specifically interact with the Hh effector to promote the 
activation of gene enhancers in the epaxial somite, where both are coexpressed (Himeda et 
al., 2013). Additionally, by qPCR we have corroborated the effect of gli2 on pax3 
expression. Moreover, other NC-expressed genes have Gli binding sites in their regulatory 
sequences. This is the case with snail1 and twist1, which are essential for NC specification 
and are upregulated by Hh during cancer initiation (Kong et al., 2015). These genes were 
also tested by qPCR and found to be regulated by gli2. Therefore, our results establish a 
novel model for further investigations to elucidate the mechanism of action of the Ihh/Gli 
signaling during NC development. Additionally, we can conclude that the importance of Gli2 
during development is thus not restricted only to the patterning of the neural tube, but 
extends to the transcriptional activation of NC inductors and specifiers during the 
morphogenesis of this cell population.  
The NC maintains a coordinated balance between proliferation and apoptosis for the 
proper organization of the derived tissues and for its migration (Le Douarin et al., 2004). 
Previous investigations in mice have shown that Shh and Ihh increase the proliferation of 
NC during the differentiation of its derivatives (Everson et al., 2017; Yang et al., 2016). Gli2 
in particular has been involved in the enhancement of proliferation during lung development 
by increasing the expression of Cyclin-D (Rutter et al., 2010). In this work we assessed 
whether this behavior of gli2 applies to the development of Xenopus NC and found that, in 
agreement with previous investigations on the role of ihh, gli2 did not alter the proliferative 
status of the NCC (Aguero et al., 2012; Tribulo et al., 2003). These findings suggest that the 
changes observed in the ectodermal marker expression could be due to cell fate decisions 
operating during gli2 gain- and loss-of-function.  
On the other hand, we found a marked reduction in the apoptotic state of NCC when gli2 
or its activator form was overexpressed. These results correlate with the proven role of the 
Hh signaling pathway in the survival of the NCC in chick and mouse models (Delloye-
Bourgeois et al., 2014; Smoak et al., 2005). Moreover, in carcinoma cells, Gli2 elicits this 
function through the transcriptional upregulation of the pro-survival gene cflip (Kump et al., 
2008). Gli2 has also been shown to promote cell survival and to interact directly with pax3 
as mentioned before (Himeda et al., 2013; Wang et al., 2011). Curiously, pax3 is one of the 
transcription factors operating in NC development, suggesting that the interaction between 

















NC migration occurs shortly after the cells have performed the EMT and become 
delaminated from the dorsal side of the embryo (Kerosuo and Bronner-Fraser, 2012; 
Kuriyama and Mayor, 2008). Cadherins in particular are important during the cell-cell 
interactions that trigger the migratory behavior of NCC (Taneyhill and Schiffmacher, 2017). 
One of the changes that are needed for NCC to become migratory involves the dissolution 
of tight cadherin-mediated adherens junctions. Our quantitative qPCR data showed that gli2 
overexpression actively increases the expression of e-cad and n-cad, which are known to 
be upregulated during the initial phase of NC migration (Cousin, 2017; Huang et al., 2016). 
This regulation highlights the role of gli2 as a regulator of NCC delamination and migration. 
Moreover, we have shown that gli2 is required for NC migration in a cell autonomous 
manner. This data is in agreement with the cell autonomous role that gli2 plays in the 
proliferation and contact inhibition of cancer cells (Alexaki et al., 2010; Regl et al., 2004).  
In most animal species, cranial NCC form the majority of the craniofacial skeleton 
(Schilling and Le Pabic, 2014). Defects in the craniofacial apparatus underlie some of the 
most common human birth defects such as cleft palate, in which Hh signaling plays a 
central role (Xavier et al., 2016). Moreover, Gli2 has been associated with the formation of 
mouse temporomandibular joint articular disk (Purcell et al., 2009). Therefore it is of crucial 
importance to understand the factors that promote the skeletogenic differentiation of cranial 
NCC in order to elucidate the mechanisms that drive human birth defects. In this work we 
strongly related gli2 function with the development of the craniofacial cartilages, which 
agrees with its role in proliferation and differentiation of chondrocytes (Joeng and Long, 
2009; Thompson et al., 2017). The abnormal development of the craniofacial cartilages 
produced by interfering with Gli2 function may reflect a deregulation of the processes that 
control NC formation and the subsequent NCC migration. A probable mechanism of this 
process could be the direct action of Gli2 upon sox9 to promote or regulate the chondrocytic 
lineage, as it is known that both proteins interact in cancer cells (Syu et al., 2016).  
Melanocytes, which are derived from the NC, are formed at all axial levels and are 
responsible for the pigmentation of the skin and hair follicles (Mort et al., 2015). Our results 
indicate that gli2 is involved in the formation of this cell lineage. Considering how gli2 
affected sox10 expression in our explant assay, we can argue that the effect observed on 
the number of melanocytes could be due to a downregulation of sox10, which is a known 
promoter of the melanocytic lineage (Aoki et al., 2003; Honoré et al., 2003).  
NCC give rise to the cranial ganglia precursors, to all Schwann cells and to the 

















Sieber-Blum, 2015). We found that gli2 was required for the formation of the Rohon-Beard 
sensory neurons and cranial ganglia precursors (in lens, the profoundal and the trigeminal 
placodes), and for tbx2 expression during the early tailbud stage. tbx2 gene is expressed 
and required for the formation of the cranial ganglia precursors of the PNS glial cells 
(Takabatake et al., 2000b) and was found to be regulated by a Gli-dependent Hh signal 
transduction pathway during Xenopus eye development (Takabatake et al., 2002). Another 
possible mechanism that could explain the reduction in Rohon-Beard neurons could be the 
direct modulation of the expression of ascl1 (Voronova et al., 2011), which participates in 
the establishment of the enteric nervous system circuitry, by itself or by repressing the 
function of sox10 (Kim et al., 2003; Memic et al., 2016). It is also possible that Gli2 is 
directly affecting sox10 expression, as this protein has also been shown to be essential for 
the development of the Rohon-Beard neurons (Olesnicky et al., 2010). However, since 
when analyzing the formation of NC derivatives we knocked down gli2 during the migration 
of the NC, we cannot definitively rule out a role of an altered NC migration in the formation 
of the NC derivatives 
Our results, integrated with previous studies, support a model in which gli2 acts 
downstream of the ihh signal secreted from the NC and from the underlying mesoderm to 
modulate the expression of different NC essential factors. This assumption was confirmed 
by the luciferase assay, in which we showed that gli2 responds to ihh to activate the 
transcription of the reporter. Additionally, in our epistatic analyses we found that gli2 and 
gli3 might act in an equivalent hierarchical position during the induction of the NC. On the 
other hand, our results have shown that gli2 acts downstream of the receptor ednra during 
NC specification, and is probably responsible for the action of the Edn1/Ednra signaling in 
promoting the cell survival of NCC during their specification (Bonano et al., 2008). 
Alternatively, a relationship between both signaling pathways could operate in the NC. This 
positive regulation between Hh and Endothelin-2 signaling pathways was established during 
the onset of basal cell carcinoma (Tanese et al., 2010). Additionally, our last epistatic 
analysis showed that eg5 acts upstream of gli2. Since Eg5 is considered an essential 
kinesin during microtubule organization and stability (Chen et al., 2017) with a participation 
in NC development different from its classical function in cell division (Fernandez et al., 
2014), it is conceivable that Eg5 could act in the process required for Gli2 translocation to 
the primary cilium of Xenopus NCC. Moreover, this kinesin is highly expressed in 
glioblastoma cells as it is the case of Gli2 (Taglieri et al., 2017). However, future studies will 

















Ednra during NC development. Our data hence support a model in which Gli2 acts 
downstream of the Ihh signaling pathway and also responds to the activities of the Ednra 
signaling and the kinesin Eg5 during the initial steps required for NC formation.  
As stated above, an improper specification, migration or differentiation of the NC can 
result in a group of diseases called neurocristopathies (NCP), which affect an appreciable 
percentage of newborns (Vega-Lopez et al., 2018). It has been shown that ciliopathies, 
which arise due to defects in the assembly or function of the primary cilia, are linked to NCP 
due to similar craniofacial defects occurring in some specific ciliopathies and NCP (Chang 
et al., 2015; Vega-Lopez et al., 2018). However, the genetics and cellular pathogenesis 
linking NCP and ciliopathies are still incompletely understood. Therefore, it is essential to 
develop suitable experimental model systems to gather more insights into the molecular 
basis underlying both diseases. Since gli2 was found to be expressed in the NC and since 
this transcription factor acts through primary cilia to activate target genes (Eggenschwiler 
and Anderson, 2007), we could speculate that this study will improve our understanding of 
the close relationship between ciliopathies and NCP. Moreover, this approach represents an 
excellent model to investigate the pathogenesis of NCP during development. Additionally, to 
the best of our knowledge, this work represents the first embryological usage of GANT61 for 
inhibiting in vivo the transcriptional activity of Gli2 and thus exploring its role during Xenopus 
development. Therefore, the use of this inhibitor could prove to be a useful tool for future 
studies. Altogether, our findings shed new light on the signal-mediated control of NC 
development by Ihh/gli signaling, and establish Gli2 as an essential factor in the 
development of the NC. Further investigations on gli2 function and its close relationships 
with other signaling pathways during Xenopus NC development will improve our 

















4. MATERIAL AND METHODS 
4.1. Embryonic Manipulation, RNA Microinjection and Lineage Tracing 
Embryos were obtained by standard procedures (Aybar et al., 2003) and staged 
according to the Nieuwkoop and Faber series (Nieuwkoop, 1967). Tissue microdissections, 
mRNA in vitro synthesis, microinjection and lineage tracing were performed as previously 
described (Aguero et al., 2012; Bonano et al., 2008; Fernandez et al., 2014; Vega-Lopez et 
al., 2015). In vitro transcribed mRNA was synthesized from pCS2+6MT_gli2 (a gift from 
Muriel Perron, also known as XGli4 (Genbank U42462, (Marine et al., 1997)) by standard 
procedures. Loss- and gain-of-function experiments through microinjection were conducted 
as follows: one dorsal blastomere of an 8-cell stage embryo (stage 3) was injected with 
mRNAs or antisense morpholino oligonucleotides (MO) at different concentrations 
(expressed as nanograms per embryo: ng/E) along with a lineage tracer, with the uninjected 
side serving as an internal control. At the desired stage the embryos were fixed with 
MEMFA and processed by ISH, IHC or another protocol specified in the text. 
 
4.2. GANT61 treatment, morpholino antisense oligonucleotides and DNA 
constructs 
In order to specifically inhibit the function of the Gli2 transcription factor in Xenopus 
laevis NC explants or whole embryos, the inhibitor GANT61 (Medchemexpress LLC, 
Princeton, NJ, USA) was used to microinject Xenopus laevis embryos and also to incubate 
NC explants. For incubation experiments, the NC explants with underlying mesoderm were 
dissected as previously described (Aguero et al., 2012). In order to spatially control Gli2 
function, heparin-sepharose beads (Affi Blue Beads, Bio-Rad, USA) were soaked into 50 
µM of GANT61 and grafted into embryos as previously described (Fernandez et al., 2014). 
GANT61-soaked beads were implanted in the right neural fold region. DMSO-soaked beads 
were grafted as a control in sibling embryos at the same position. In order to inhibit the 
translation of the gli2 mRNA, a morpholino antisense oligonucleotide (gli2MO) was 
designed and synthesized including the initiation start site (from +1 to +24 bp) with the 
sequence shown in Supplementary Table 1 (Gene Tools, LLC). Doses of 5–27 ng/E were 
microinjected with a lineage tracer into one blastomere in 8- or 16-cell stage embryos. A 
control antisense morpholino oligonucleotide (CoMO) composed of a random sequence was 
injected as a control. For the knock-down of gli3, ihh, eg5 and ednra mRNAs, specific 

















was used as a template for DNA constructs and in vitro mRNA synthesis. In order to test the 
efficacy of gli2MO in vivo, a pCS2+gli2GFP fusion was generated by high-fidelity PCR using 
pCS2+MT_gli2 as the template with the primers shown in Table 2. A fragment containing 
the N-region of Gli2 encoding 277 amino acid residues of Gli2 was cloned into the pTOPO-
TA vector (giving rise to pTOPO-gli2), amplified and then subcloned directionally into BamHI 
and NcoI sites in pCS2+eGFP vector to produce the gli2GFP construct. In vitro transcribed 
mRNA (2.6 ng/E) of this construct was coinjected with different amounts of gli2MO and the 
GFP fluorescence was observed under a Leica fluorescence stereomicroscope. For the 
rescue of morpholino knock-down experiments, a DNA construct was prepared by changing 
specifically the codon sequence targeted by the gli2MO antisense oligonucleotide. Special 
caution was taken to mutate the DNA sequence without changing the wild type gli2 amino 
acid sequence. This construct, made by high fidelity PCR and named pCS2+MT-CRgli2 
(CR, Codon Replacement), introduced 6 silent mutations in the nucleotide sequence 
recognized by the morpholino.  
In order to test the different functional variables of Gli2, we generated an activator and a 
repressor Gli2 construct, gli2act (pCS2+MT-Gli2act) and gli2rep (pCS2+MT-Gli2rep), 
respectively. The activator construct lacks the N-terminal repressor region of Gli2 and the 
repressor plasmid lacks the C-terminal activator domain of this protein. These constructs 
were generated with the primers indicated in Table 1, using pCS2+MT_gli2 as the template.  
The construct gli2PSM (pCS2+MT-gli2PSM-6xHIS) was generated by site directed 
mutagenesis and encoded a myc tag in the N-terminal region and a 6xHIS tag in the C-
terminal region. Additionally, it has the six PKA-phosphorylatables serine residues mutated 
into non-phosphorylatable alanines. In order to specifically direct the overexpression of gli2 
functional variables to the NCC, the α3000 snail2 promoter (Vallin et al., 2001) was fused 
upstream to the full length gli2 sequence. The α3000gli2 (Alpha-3000-gli2) DNA construct 
was prepared from BamHI/NotI digested pTOPO-Gli2 and ligated into SB*XlpSlα3000-GFP 
plasmid. The α3000gli2 plasmid was purified and 200–400 pg/embryo were microinjected 
into one blastomere of 8- to 16-cell embryos. Fluorescence was observed since stage 13. 
Similarly, the constructs α3000-CRgli2 (Alpha-3000-gli2), α3000-gli2act (Alpha-3000-
gli2act) and α3000-CRgli2PSM (Alpha-3000-CRgli2PSM) were prepared using the primers 
described in Supplementary Table 2. All constructs prepared in this work were sequenced 
on both strands by automated DNA sequencing and are shown in Supplementary Figure 1. 


















4.3. in situ hybridization, immunohistochemistry and caspase activity 
measurement  
The ISH protocol was performed as previously described (Aybar et al., 2003). 
Phenotypes obtained by ISH were double-blind counted by two lab members. The NC gene 
expression areas of treated and injected sides of at least 5 embryos for each treatment or 
condition were measured and quantified using the ImageJ software (NIH, USA) in 3-5 
photographs per embryo. The expression of a gene marker was considered increased or 
decreased when compared to the control side showed a difference of at least 25% in the 
average values of gene expression between control and treated sides. 
Antisense probes containing Digoxigenin-11-UTP or Fluorescein-12-UTP were prepared 
from the clones indicated in Supplementary Table 3. Apoptosis in NC was detected by 
Caspase 3/7 activity using the Apo-ONE homogeneous assay (Promega, Madison, WI) 
according to the manufacturer’s instructions as described previously. In detail, NC explants 
were dissected from midneurula stage embryos. The explants were then resupended in 50 
µl of NAM 3/8 and 50 µl of the Apo-One Caspase 3/7 reagent. After mixing by pipetting to 
homogenize the tissue, the samples were incubated 40 min at room temperature and the 
fluorescence was measured as arbitrary fluorescence units in a Perkin-Elmer LS55 
fluorescence spectrometer (excitation wavelength 499 nm, emission wavelength 521 nm). 
The Caspase 3/7 activity was expressed as the ratio to the uninjected embryo (Caspase 
Arbitrary Unit = 1). (Fernandez et al., 2014). IHC for Ptch1 and phosphohistone was 
performed as described previously (Vega-Lopez et al., 2015). The anti-Ptch1 antibody used 
was obtained from the Developmental Studies Hybridoma Bank (DSHB, USA, clone Apa1) 
while the rabbit Polyclonal anti-phosphohistone-3 antibody was obtained from Upstate 
Biotechnology, Lake Placid, NY). Student’s t-test was used to analyze the differences 
between each of the groups for Caspase 3/7 activity with respect to the corresponding 
control group. ANOVA analysis (InfoStat 2011, (Di Rienzo et al., 2011) was used to 
determine statistical differences (P ≤ 0.05) between Caspase 3/7 activity and the control 
group. Tukey’s test was also used (α ≤ 0.05). All experiments were repeated twice. 
 
4.4. Cartilage staining, RNA isolation from embryos and RT-qPCR analysis, 
Western blot and luciferase assay. 
Cartilage staining was performed as previously described (Vega-Lopez et al., 2015). For 
the RT-qPCR study of gli2 function, total RNA was isolated from NC explants using the 

















transcription was performed starting from 2 μg of total RNA using the M-MLV Reverse 
Transcriptase (Promega) and Oligo (dT) primers. Real-time PCR was done on 1 μl of 
dilutional series of cDNA starting from a dilution of factor 5 using Mezcla Real 
(Biodynamics). PCR amplification was monitored with a CFX96 Real-Time System (Bio-
Rad). After one incubation step at 95°C for 7 min, the thermal cycling protocol was as 
follows: 95°C for 10 seconds, 60°C for 15 seconds and 72°C for 15 seconds during 40 
cycles. The primers designed for this study are shown in Supplementary Table 4. Target 
genes were analyzed using standard curves to determine relative levels of gene expression, 
and individual cDNA samples were normalized according to the levels of gapdh. For each 
primer set, the efficiency of the PCR reaction was measured in duplicate on serial dilutions 
(factor 5) of the cDNA sample. Real-time PCR efficiencies (E) for each reaction were 
calculated from the slope of the standard curve using the BioRad CFX manager V3 
software, with 100% efficiency as an indicator of a robust assay. Statistics were generated 
using Excel and p values determined using paired, 2-tailed Student’s t-Test. Error bars 
represent average ± s.d. All results reported here are averages of two independent reverse 
transcription reactions, which have been each tested with two qPCR reactions. For 
quantification, data were analyzed by the 2-DDCT method (Livak and Schmittgen, 2001), by 
normalizing to the housekeeping gene gapdh (glyceraldehyde-3-phosphate dehydrogenase) 
and to the uninjected NC. Finally, qPCR results were represented showing each gene 
expression level in treated explants normalized to the level of expression of wildtype 
uninjected NC explants.  
For the control of the efficiency of the gli2MO Western blots were performed as 
described (Bonano et al., 2008; Fernandez et al., 2014). Protein extracts were obtained 
from 10 gli2MO- and pCS2+gli2GFP-injected embryos at stage 15 for each experimental 
group and processed for Western blot assay using anti-GFP, 1:1000 (Invitrogen) and anti-
alpha-tubulin 1:1500 (DSHB, 12G10 clone). The alpha-tubulin antibody was used as a 
loading control. After electrophoresis and electrotransference, nitrocellulose membranes 
were incubated with primary antibodies overnight at 4ºC followed by 2 h incubation with the 
secondary antibody. The secondary antibodies were peroxidase-conjugated (cat. # AM-P1, 
Endocrinology Lab, Universidad Nacional del Litoral, Argentina) and alkaline phosphatase 
(AP)-conjugated (cat. # A0162, Sigma Aldrich) 1:750. The substrates for colorimetric 
detection were BCIP (cat #94550364, Roche, USA) and NBT (cat. # 94550571, Roche, 

















(Kalium Tech, Buenos Aires, Agentina). Labeling detection and documentation was 
performed using a C-Digit scanner (LI-COR Biosciences). 
For the luciferase assay, stage 3 embryos were injected with the reporter plasmid 
8xGBS-LucII-pCS2+ (a kind gift from Stephan Teglund) (300pg/E) and the control reporter 
plasmid pGL4.74-TK-hRluc (200pg/E). Along with the reporter constructs, mRNAs and MOs 
were also injected to analyze the transcriptional mechanism involving Gli2. At stages 15-16, 
60 NC explants were extracted and homogenized with Passive Lysis Buffer (Promega). 
Then luciferase activity was measured by a commercial kit (Dual-Luciferase Reporter Assay 
System, Promega, WI, USA) using the Synergy HTX microplate reader (Biotek, Winooski, 
VT, USA). Results are representative of two independent experiments. 
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 A complete spatio-temporal expression pattern of gli2 in Xenopus laevis was investigated. gli2 is 
expressed in the premigratory and migratory neural crest.  
 
 Gli2 acts as a transcriptional activator in the neural crest and modulates the expression of neural 
plate border and neural crest genes.  
 
 Gli2 does not affect cell proliferation but enhances survival of neural crest cells.  
 
 Neural crest migration requires gli2 in a cell autonomous manner.  
 
 gli2 participates in the formation of craniofacial cartilages, Rohon-Beard neurons, cranial ganglia 
primordia and melanocytes.  
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